Ossen Innovation Announces Termination of Share Exchange Agreement with America-Asia Diabetes Research Foundation
About
Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company's public filings with the Securities and Exchange Commission, including the Company's annual report on Form 20-F. All information provided in this press release is as of the date hereof. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
For more information, please contact:
Phone: +86-21-6888-8886
Web: http://www.osseninnovation.com
View original content:http://www.prnewswire.com/news-releases/ossen-innovation-announces-termination-of-share-exchange-agreement-with-america-asia-diabetes-research-foundation-300643734.html
SOURCE